RIZZOTTO, Lara
 Distribuzione geografica
Continente #
NA - Nord America 3.937
AS - Asia 2.039
EU - Europa 1.123
SA - Sud America 246
AF - Africa 41
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.391
Nazione #
US - Stati Uniti d'America 3.849
SG - Singapore 786
CN - Cina 507
DE - Germania 267
VN - Vietnam 249
BR - Brasile 193
IT - Italia 166
UA - Ucraina 152
HK - Hong Kong 134
GB - Regno Unito 126
TR - Turchia 121
FI - Finlandia 77
FR - Francia 76
BD - Bangladesh 73
RU - Federazione Russa 59
SE - Svezia 59
CA - Canada 52
JP - Giappone 48
IN - India 42
MX - Messico 30
ES - Italia 25
BE - Belgio 20
PL - Polonia 20
CZ - Repubblica Ceca 19
ID - Indonesia 18
ZA - Sudafrica 16
NL - Olanda 14
AR - Argentina 13
LT - Lituania 12
PK - Pakistan 12
CO - Colombia 10
CL - Cile 9
VE - Venezuela 9
IQ - Iraq 8
MA - Marocco 8
RO - Romania 7
MY - Malesia 6
AT - Austria 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BO - Bolivia 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
JO - Giordania 3
PH - Filippine 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LY - Libia 2
MT - Malta 2
NG - Nigeria 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TZ - Tanzania 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 7.391
Città #
Singapore 513
Ashburn 471
Woodbridge 358
San Jose 284
Chandler 254
Fairfield 252
Beijing 207
Santa Clara 180
Jacksonville 171
Houston 152
Ann Arbor 150
Hong Kong 130
Seattle 112
Wilmington 101
Cambridge 97
Dallas 97
New York 94
Ho Chi Minh City 82
Los Angeles 72
Izmir 64
Munich 61
Hanoi 58
Ferrara 49
Tokyo 45
Nanjing 42
Princeton 38
Shanghai 36
Milan 35
Lauterbourg 34
Boardman 33
São Paulo 27
Helsinki 23
San Diego 23
Bremen 22
London 22
Orem 22
Buffalo 21
Mexico City 20
Brussels 19
Turku 19
Shenyang 18
Warsaw 18
Dearborn 17
Denver 17
Montreal 17
Frankfurt am Main 16
Nanchang 16
Addison 15
Brno 15
The Dalles 14
Tianjin 14
Brooklyn 13
Changsha 13
Johannesburg 13
Stockholm 13
Da Nang 12
San Francisco 12
Chennai 11
Manchester 11
Toronto 11
Amsterdam 10
Guangzhou 10
Chicago 9
Jiaxing 9
Jinan 9
Moscow 9
Mumbai 9
Zhengzhou 9
Atlanta 8
Bologna 8
Falkenstein 8
Haiphong 8
Jakarta 8
Phoenix 8
Poplar 8
Auburn Hills 7
Biên Hòa 7
Columbus 7
Dortmund 7
Hefei 7
Mountain View 7
Paris 7
Reynoldsburg 7
Rio de Janeiro 7
Council Bluffs 6
Norwalk 6
Orange 6
Washington 6
Bexley 5
Boston 5
Bến Tre 5
Caracas 5
Falls Church 5
Guarulhos 5
Ninh Bình 5
Secaucus 5
Augusta 4
Calgary 4
Can Tho 4
Hải Dương 4
Totale 5.049
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 292
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 269
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 254
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 248
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 247
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 244
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 243
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 228
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 227
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 225
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 221
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 210
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 207
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 206
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 197
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 196
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 195
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 192
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 189
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 187
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 179
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 177
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 172
Rescue of coagulation factor VII function by the U1+5A snRNA 170
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 169
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 163
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 154
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 152
Non-conventional therapeutic strategies for inherited disorders of hemostasis 149
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 137
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 134
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 129
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 129
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 124
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 111
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 108
null 94
null 82
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 79
null 64
null 42
Totale 7.436
Categoria #
all - tutte 30.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022442 38 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024233 25 26 9 3 12 50 9 12 8 6 3 70
2024/2025986 14 24 73 45 137 107 9 22 162 91 142 160
2025/20263.063 333 113 242 380 468 223 394 164 243 284 150 69
Totale 7.436